Abstract
High-grade craniofacial osteosarcoma (CFOS) is an aggressive malignancy with a poor prognosis. Our goals were to evaluate treatment outcomes in those treated at a single referral institution over 35 years and to compare our results to the available literature. A retrospective analysis of all 42 patients treated between 1980 and 2015 at Oslo University Hospital, Norway, identified in a prospectively collected database, was conducted. Mean follow-up was 79.6 months. Overall survival at 2 and 5 years was 70.5 and 44.7%, respectively. The corresponding disease-specific survival rates were 73.0 and 49.8%. Treatment was surgery only in eight cases. Additional therapy was administered in 34 patients: chemotherapy in nine, radiotherapy in seven, and a combination of these in 18 cases. Stratified analysis by resection margins demonstrated significantly better survival at 2 and 5 years after radical surgical treatment. Neoadjuvant chemotherapy and subsequent adequate surgery resulted in better survival than surgery alone. Half of the patients either had a primary or familial cancer predisposition. This is the largest single-center study conducted on high-grade CFOS to date. Our experience indicates that neoadjuvant chemotherapy with complete surgical resection significantly improved survival, compared to surgery alone.
Similar content being viewed by others
References
Hogendoorn PC, Group EEW, Athanasou N, Bielack S, De Alava E, Dei Tos AP et al (2010) Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v204–v213
Mirabello L, Troisi RJ, Savage SA (2009) International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 125(1):229–234
Fletcher C, Bridge J, Hogendoorn PC, Mertens F (2013) WHO classification of tumours of soft tissue and bone, 4th edn. International Agency for Research on Cancer, Lyon
Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bohler PJ et al (2015) Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncol 54(1):25–33
Tran LM, Mark R, Meier R, Calcaterra TC, Parker RG (1992) Sarcomas of the head and neck. Prognostic factors and treatment strategies. Cancer 70(1):169–177
Saeter G, Bruland OS, Folleras G, Boysen M, Hoie J (1996) Extremity and non-extremity high-grade osteosarcoma—the Norwegian Radium Hospital experience during the modern chemotherapy era. Acta Oncol 35(Suppl 8):129–134
Thiele OC, Freier K, Bacon C, Egerer G, Hofele CM (2008) Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study. Br J Oral Maxillofac Surg 46(7):533–536
Berner K, Hall KS, Monge OR, Weedon-Fekjaer H, Zaikova O, Bruland OS (2015) Prognostic factors and treatment results of high-grade osteosarcoma in Norway: a scope beyond the “classical” patient. Sarcoma 2015:516843
Luetke A, Meyers PA, Lewis I, Juergens H (2014) Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev 40(4):523–532
Huvos AG, Rosen G, Marcove RC (1977) Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101(1):14–18
Fletcher C, Unni K (2002) Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon
Saeter G, Bruland O (1998) High-grade osteosarcoma: the scope beyond the classical patient. Towards the Eradication of Osteosarcoma Metastasis-An Odyssey 21-3
Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50(3):163–170
Cox D (1972) Regression models and life tables. J R Stat Soc B 34:187–220
Fisher RA (1922) On the interpretation of Χ2 from contingency tables, and the calculation of P. J R Stat Soc 85(1):87–94
Bruland OS, Bauer H, Alvegaard T, Smeland S (2009) Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience. Cancer Treat Res 152:309–318
Huber GF, Dziegielewski P, Wayne Matthews T, Dort JC (2008) Head and neck osteosarcoma in adults: the province of Alberta experience over 26 years. J Otolaryngol Head Neck Surg 37(5):738–743
Sturgis EM, Potter BO (2003) Sarcomas of the head and neck region. Curr Opin Oncol 15(3):239–252
Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM (2009) Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer 115(14):3262–3270
Kassir RR, Rassekh CH, Kinsella JB, Segas J, Carrau RL, Hokanson JA (1997) Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope 107(1):56–61
Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S (2009) The role of radiotherapy in osteosarcoma. Cancer Treat Res 152:147–164
Kammerer PW, Shabazfar N, Vorkhshori Makoie N, Moergel M, Al-Nawas B (2012) Clinical, therapeutic and prognostic features of osteosarcoma of the jaws—experience of 36 cases. J Craniomaxillofac Surg 40(6):541–548
Patel SG, Meyers P, Huvos AG, Wolden S, Singh B, Shaha AR et al (2002) Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer 95(7):1495–1503
Konig M, Mork J, Hall KS, Osnes T, Meling TR (2010) Multimodal treatment of osteogenic sarcoma of the jaw. Skull Base 20(3):207–212
Jasnau S, Meyer U, Potratz J, Jundt G, Kevric M, Joos UK et al (2008) Craniofacial osteosarcoma experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol 44(3):286–294
Mendenhall WM, Fernandes R, Werning JW, Vaysberg M, Malyapa RS, Mendenhall NP (2011) Head and neck osteosarcoma. Am J Otolaryngol 32(6):597–600
Ferrari D, Codeca C, Battisti N, Broggio F, Crepaldi F, Violati M et al (2014) Multimodality treatment of osteosarcoma of the jaw: a single institution experience. Med Oncol 31(9):171
Mark RJ, Sercarz JA, Tran L, Dodd LG, Selch M, Calcaterra TC (1991) Osteogenic sarcoma of the head and neck. The UCLA experience. Arch Otolaryngol Head Neck Surg 117(7):761–766
Oda D, Bavisotto LM, Schmidt RA, McNutt M, Bruckner JD, Conrad EU 3rd et al (1997) Head and neck osteosarcoma at the University of Washington. Head Neck 19(6):513–523
Ha PK, Eisele DW, Frassica FJ, Zahurak ML, McCarthy EF (1999) Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope 109(6):964–969
Gorsky M, Epstein JB (2000) Craniofacial osseous and chondromatous sarcomas in British Columbia—a review of 34 cases. Oral Oncol 36(1):27–31
Smith RB, Apostolakis LW, Karnell LH, Koch BB, Robinson RA, Zhen W et al (2003) National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 98(8):1670–1680
Garrington GE, Scofield HH, Cornyn J, Hooker SP (1967) Osteosarcoma of the jaws. Analysis of 56 cases. Cancer 20(3):377–391
Roca AN, Smith JL Jr, Jing BS (1970) Osteosarcoma and parosteal osteogenic sarcoma of the maxilla and mandible: study of 20 cases. Am J Clin Pathol 54(4):625–636
Caron AS, Hajdu SI, Strong EW (1971) Osteogenic sarcoma of the facial and cranial bones. A review of forty-three cases. Am J Surg 122(6):719–725
Russ JE, Jesse RH (1980) Management of osteosarcoma of the maxilla and mandible. Am J Surg 140(4):572–576
Nora FE, Unni KK, Pritchard DJ, Dahlin DC (1983) Osteosarcoma of extragnathic craniofacial bones. Mayo Clin Proc 58(4):268–272
Clark JL, Unni KK, Dahlin DC, Devine KD (1983) Osteosarcoma of the jaw. Cancer 51(12):2311–2316
Forteza G, Colmenero B, Lopez-Barea F (1986) Osteogenic sarcoma of the maxilla and mandible. Oral Surg Oral Med Oral Pathol 62(2):179–184
Bertoni F, Dallera P, Bacchini P, Marchetti C, Campobassi A (1991) The Istituto Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer 68(7):1555–1563
Vege DS, Borges AM, Aggrawal K, Balasubramaniam G, Parikh DM, Bhaser B (1991) Osteosarcoma of the craniofacial bones. A clinico-pathological study. J Craniomaxillofac Surg 19(2):90–93
Wanebo HJ, Koness RJ, MacFarlane JK, Eilber FR, Byers RM, Elias EG et al (1992) Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 14(1):1–7
Salvati M, Ciappetta P, Raco A (1993) Osteosarcomas of the skull. Clinical remarks on 19 cases. Cancer 71(7):2210–2216
Delgado R, Maafs E, Alfeiran A, Mohar A, Barrera JL, Zinser J et al (1994) Osteosarcoma of the jaw. Head Neck 16(3):246–252
Koka V, Vericel R, Lartigau E, Lusinchi A, Schwaab G (1994) Sarcomas of nasal cavity and paranasal sinuses: chondrosarcoma, osteosarcoma and fibrosarcoma. J Laryngol Otol 108(11):947–953
August M, Magennis P, Dewitt D (1997) Osteogenic sarcoma of the jaws: factors influencing prognosis. Int J Oral Maxillofac Surg 26(3):198–204
van Es RJ, Keus RB, van der Waal I, Koole R, Vermey A (1997) Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg 26(3):191–197
Canadian Society of O-H, Neck Surgery Oncology Study G (2004) Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000). J Otolaryngol 33(3):139–144
Fernandes R, Nikitakis NG, Pazoki A, Ord RA (2007) Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg 65(7):1286–1291
Laskar S, Basu A, Muckaden MA, D’Cruz A, Pai S, Jambhekar N et al (2008) Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients. Head Neck 30(8):1020–1026
Paparella ML, Olvi LG, Brandizzi D, Keszler A, Santini-Araujo E, Cabrini RL (2013) Osteosarcoma of the jaw: an analysis of a series of 74 cases. Histopathology 63(4):551–557
Lim S, Lee S, Rha SY, Rho JK (2013) Craniofacial osteosarcoma: single institutional experience in Korea. Asia Pac J Clin Oncol
Smeele LE, Kostense PJ, van der Waal I, Snow GB (1997) Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 15(1):363–367
Smeele LE, Snow GB, van der Waal I (1998) Osteosarcoma of the head and neck: meta-analysis of the nonrandomized studies. Laryngoscope 108(6):946
Smeele LE, van der Wal JE, van Diest PJ, van der Waal I, Snow GB (1994) Radical surgical treatment in craniofacial osteosarcoma gives excellent survival. A retrospective cohort study of 14 patients. Eur J Cancer B Oral Oncol 30B(6):374–376
Akbiyik N, Alexander LL (1981) Osteosarcoma of the maxilla treated with radiation therapy and surgery. J Natl Med Assoc 73(4):355–356
Briant TD, Bird R (1981) Osteogenic sarcoma of the mandible. J Otolaryngol 10(2):149–161
deFries HO, Perlin E, Leibel SA (1979) Treatment of osteogenic sarcoma of the mandible. Arch Otolaryngol 105(6):358–359
Goepfert H, Ballantyne AJ, Matalon V, McCarthy E (1979) Osteogenic sarcoma of the mandible: surgical resection and prosthetic rehabilitation. Otolaryngol Head Neck Surg (1979) 87(4):417–419
Gomez AC, Youmans RD, Chambers RG (1960) Osteogenic sarcoma of the mandible. A method of treatment. Am J Surg 100:613–616
Hadley C, Gressot LV, Patel AJ, Wang LL, Flores RJ, Whitehead WE et al (2014) Osteosarcoma of the cranial vault and skull base in pediatric patients. J Neurosurg Pediatr 13(4):380–387
Kragh LV, Dahlin DC, Erich JB (1958) Osteogenic sarcoma of the jaws and facial bones. Am J Surg 96(4):496–505
LiVolsi VA (1977) Osteogenic sarcoma of the maxilla. Arch Otolaryngol 103(8):485–488
Mardinger O, Givol N, Talmi YP, Taicher S (2001) Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91(4):445–451
Schwartz DT, Alpert M (1963) The clinical course of mandibular osteogenic sarcoma. Oral Surg Oral Med Oral Pathol 16:769–776
van den Berg H, Schreuder WH, de Lange J (2013) Osteosarcoma: a comparison of jaw versus nonjaw localizations and review of the literature. Sarcoma 2013:316123
Sundaresan N, Huvos AG, Rosen G, Galicich JH (1985) Combined-modality treatment of osteogenic sarcoma of the skull. J Neurosurg 63(4):562–567
Huvos AG, Sundaresan N, Bretsky SS, Butler A (1985) Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. Cancer 56(5):1214–1221
Boon E, van der Graaf WT, Gelderblom H, Tesselaar ME, van Es RJ, Oosting SF, et al. (2016) Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults. Head Neck
Carrle D, Bielack SS (2006) Current strategies of chemotherapy in osteosarcoma. Int Orthop 30(6):445–451
Isakoff MS, Bielack SS, Meltzer P, Gorlick R (2015) Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol 33(27):3029–3035
Bielack SS, Wulff B, Delling G, Gobel U, Kotz R, Ritter J et al (1995) Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS). Med Pediatr Oncol 24(1):6–12
Bilsky MH, Bentz B, Vitaz T, Shah J, Kraus D (2005) Craniofacial resection for cranial base malignancies involving the infratemporal fossa. Neurosurgery 57(4 Suppl):339–347 discussion -47
Anninga JK, Gelderblom H, Fiocco M, Kroep JR, Taminiau AH, Hogendoorn PC et al (2011) Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur J Cancer 47(16):2431–2445
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM et al (2015) Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: first results of the EURAMOS-1 good response randomized controlled trial. J Clin Oncol 33(20):2279–2287
Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P et al (2005) Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 23(34):8845–8852
Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM (2005) Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys 62(4):1070–1077
Acknowledgements
The authors would like to thank Dr. Kjetil Berner and Dr. Olga Zaikova for their valuable feedback. They would also like to extend their gratitude to Trine Thoresen for maintaining the sarcoma database at the Norwegian Radium Hospital.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Ethical approval
This study was approved by the data protection official at OUH. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study does not contain any studies with animals performed by any of the authors.
Informed consent
For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
König, M., Osnes, T.A., Lobmaier, I. et al. Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years. Neurosurg Rev 40, 449–460 (2017). https://doi.org/10.1007/s10143-016-0802-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-016-0802-z